HLA-B and graft versus host disease: In CB HCT, matching for alleles HLA-A, HLA-B and HLA-DR (i.e. ≥ 4 of 6 HLA match) is sufficient to reduce the incidence of graft-versus-host disease (GvHD) to a low level (48).